SIASUN(SZ:300024) Di Yi Cai Jing Zi Xun·2026-01-11 05:12Core Viewpoint - Elon Musk predicts that general artificial intelligence (AGI) will arrive by 2026, with robots surpassing human surgeons in surgical skills within three years and achieving complete superiority over any human surgeon in four years [2][4]. Group 1: Impact on the Medical Industry - Musk's statements have caused significant concern within the global medical community, suggesting a potential crisis for doctors [4]. - The concept of AGI refers to artificial intelligence systems that possess cognitive abilities comparable to or exceeding those of humans, capable of performing complex tasks and learning autonomously [4]. - Neuralink, Musk's brain-machine interface company, is already using robots for "brain insertion" surgeries, with over 10,000 patients reportedly waiting for procedures [4][5]. Group 2: Technological Advancements - Neuralink's surgical robots have dramatically reduced the time required to implant electrodes from 17 seconds to 1.5 seconds, aiming for a future where surgeries can be completed in a short time frame [5]. - The robots utilize a complex visual system that integrates multiple microscopes and optical coherence tomography (OCT) technology to enhance precision during surgeries [5]. Group 3: Challenges in Implementation - Significant engineering challenges remain in automating all decision-making processes for surgical robots, as current operations still require human oversight [6][7]. - The transition from experimental technology to widespread clinical application will necessitate a fully automated maintenance system for the robots [6]. Group 4: Perspectives from Medical Professionals - Experts believe that while AI will assist doctors, the complete replacement of human surgeons is not imminent, with many emphasizing the need for human oversight in surgical procedures [9][10]. - Current robotic systems, including the Da Vinci robot, still rely on human operators, and achieving fully autonomous surgical robots is seen as a long-term goal [10]. Group 5: Investment Landscape - The surgical robot market in China has become highly attractive for investors, with significant funding activity and several companies seeking to capitalize on this trend [12]. - The market is currently dominated by a few leading companies, making it challenging for new entrants to gain a foothold [12]. - The Chinese vascular intervention robot market is projected to grow significantly, with an estimated market size of 5.824 billion RMB by 2030, reflecting a compound annual growth rate of 90% [15]. Group 6: Regulatory Developments - The National Healthcare Security Administration in China is expected to release guidelines for the pricing of surgical robots and related technologies, which could positively impact the industry [14].